Capricor Therapeutics (CAPR) Misses Q3 EPS by 2c, provides outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 8.01 -0.09 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.10 | 52 Week High | $5.40 | |||
| Open | $7.89 | 52 Week Low | $1.88 | |||
| Day High | $8.17 | P/E | N/A | |||
| Day Low | $7.80 | EPS | $0.00 | |||
| Volume | 2,513,270 | |||||
